课题基金 / 基金详情

Genetic and epigenetic architecture of natural telomere length variation

Genetic and epigenetic architecture of natural telomere length variation
自然端粒长度变异的遗传和表观遗传结构
批准号:
10046874
负责人:
Eugene V Shakirov
金额:
$29.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2022-05-31

项目摘要

项目成果

Eugene V Shakirov的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary Telomeres are evolutionarily conserved protein-DNA complexes at the physical ends of linear eukaryotic chromosomes. Telomeres shorten with age in most human cells, and their initial length pre-determines cellular lifespan. Mutations in telomere maintenance genes lead to cancer, premature aging and a number of age-related disorders. While mean telomere length in humans shows considerable inter-individual variation and appears to be under strong genetic control, the exact nature of factors establishing telomere length set point remains elusive. In our preliminary results using the model plant Arabidopsis thaliana we identify a major effect QTL in a recombinant inbred population that explains 48% of telomere length variation and map this QTL to a candidate gene, NOP2A. Notably, expression of the human NOP2 ortholog is linked to tumorigenesis and serves as a prognostic marker of tumor development. In this proposal, we will utilize genetic, genomic, biochemical and epigenetic approaches to decipher the mechanism of AtNOP2A function, and to uncover additional genetic and epigenetic factors involved in telomere length control. In Aim 1, through a series of quantitative transgenic rescue experiments we will identify the causal SNP and explore the mechanism by which NOP2A impacts telomere length. We will also employ powerful Arabidopsis genetic, genomic and transcriptomic tools to identify and characterize NOP2A-dependent genes and trans-regulators. In Aim 2, we will perform GWAS in 1,001 Arabidopsis genotypes and fine-map additional QTL in a bi-parental Arabidopsis RIL population to identify novel polymorphisms that affect telomere length. We will then perform a series of knock-out and transgenic rescue experiments to functionally characterize candidate genes and validate their role in telomere biology. In Aim 3, we will utilize a unique A. thaliana epigenetic recombinant inbred population with almost identical DNA sequences, but variable methylation and gene expression profiles, to fine-map two previously identified large-effect epi-QTL governing telomere length, and analyze how heritable epigenetic variation directly affects telomere length. Overall, the results of this study are expected to significantly increase understanding of genetic differences underlying telomere length polymorphism in natural Arabidopsis populations. Because modes of telomere regulation are highly conserved, our data may also provide novel insight into the molecular basis for different rates of aging and predisposition to diseases associated with telomere abnormalities in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic and epigenetic architecture of natural telomere length variation
  • 批准号:
    10446527
  • 项目类别:
  • 资助金额:
    $31.35万
  • 财政年份:
    2018
  • 负责人:
    Eugene V Shakirov
  • 依托单位:
Genetic and epigenetic architecture of natural telomere length variation
  • 批准号:
    9923707
  • 项目类别:
  • 资助金额:
    $27.27万
  • 财政年份:
    2018
  • 负责人:
    Eugene V Shakirov
  • 依托单位:
Genetic and epigenetic architecture of natural telomere length variation
  • 批准号:
    10626849
  • 项目类别:
  • 资助金额:
    $29.26万
  • 财政年份:
    2018
  • 负责人:
    Eugene V Shakirov
  • 依托单位:
Identification and analysis of genetic determinants of natural telomere length variation
  • 批准号:
    9262152
  • 项目类别:
  • 资助金额:
    $7.83万
  • 财政年份:
    2016
  • 负责人:
    Eugene V Shakirov
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: